Investor Ab

Institutional investor · Portfolio as of Q2 2020

Q2 2020 Summary

Held steady with 4 unchanged positions. Portfolio: $2.3B across 4 positions.

Top Holdings4 positions

Checking export access…
Activity:
NDAQ

Nasdaq, Inc.

19.4M$2.3B99.4%$32.48+12.54%
3 qtrssince 2019-Q4
Unchanged
0
AGRX
AGRXDelisted

AGILE THERAPEUTICS INC

3.5M$9.8M0.4%——
3 qtrssince 2019-Q4
Unchanged
0
STIM

Neuronetics, Inc.

1.8M$3.5M0.1%$4.49-57.02%
3 qtrssince 2019-Q4
Unchanged
0
HOLI
HOLIDelisted

HOLLYSYS AUTOMATION TCHNGY L

30,000$399,0000.0%——
2 qtrssince 2020-Q1
Unchanged
0
$2.3B
AUM
4
Positions
Q2 2020
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2020-Q1$1,851,781,000-11.6962851307%
2020-Q2$2,330,638,00025.8592673756%
Activity profile
$ moved · Q2'20
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.8 quarters
<1Q0%1-4Q75%1-2Y0%2Y+25%

Investor Ab manages $2.3B across 4 positions as of Q2 2020. Top holdings: NDAQ (99.4%), AGRX (0.4%), STIM (0.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$2B
NDAQ99.42%
AGRX0.42%
STIM0.15%
HOLI0.02%

Portfolio allocation by GICS sector

Sectors3
Financial Services99.42%
Unknown0.44%
Healthcare0.15%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L33
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used